Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

Standard treatment for muscle-invasive bladder cancer is neoadjuvant chemotherapy followed by radical cystectomy, but more than half of all patients relapse within 3 years. Previous trials of ...

Perioperative durvalumab has “the potential to transform the standard of care” for patients with muscle-invasive bladder ...

Platinum-based chemotherapy has long been the standard treatment for metastatic bladder cancer and for muscle-invasive bladder cancer where neoadjuvant chemotherapy is delivered prior to surgery.

even during cancer treatment. Scientists also revealed that circular fragments of DNA called extrachromosomal DNA (ecDNA) is ...

Analysis of 20 Independently Performed Assays to Measure Homologous Recombination Deficiency (HRD) in Ovarian Cancer: Findings From the Friends ... are usually followed with adjuvant radiation therapy ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Patients with dMMR colon cancer in a trial for two neoadjuvant cycles of nivolumab/ipilimumab or nivolumab/relatlimab, had ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.

BMI's Relation to Cancer Therapy Mortality Risks Not So Straightforward ... 2024 — Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy -- given ...

Platinum-based chemotherapy has long been the standard treatment for metastatic bladder cancer and for muscle-invasive ...